Export

EN
FR
Budesonide
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03BA02
EMLc
Indication
Asthma ICD11 code: CA23
INN
Budesonide
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Respiratory > Inhalation > powder: 100 µg per actuation in dry powder inhaler ; 200 µg per actuation in dry powder inhaler
Respiratory > Inhalation > suspension: 100 µg per actuation in pressurized metered dose inhaler ; 200 µg per actuation in pressurized metered dose inhaler
EML status history
First added in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
beclometasone (ATC codes: R03BA01)
ciclesonide (ATC codes: R03BA08)
fluticasone (ATC codes: R03BA05)
mometasone (ATC codes: R03BA07)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Budesonide
DrugBank
Budesonide
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of budesonide on the EML and EMLc: - update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics; - to remove flunisolide as a therapeutic alternative to budesonide from the EML and EMLc due to low market availability.